No Way To Go But Grow: J&J Outlines Plans To Become A $60bn Pharma In 2025

 
• By Jessica Merrill

Management outlined its growth strategy to investors, highlighting plans to file 14 novel drugs with more than $1bn in peak sales by 2025.

Janssen Pharmaceutica sign and logo
J&J outlined growth plans for its Janssen pharmaceutical unit • Source: Alamy

More from Strategy

More from Business